189
Views
8
CrossRef citations to date
0
Altmetric
Drug Profile

Sufentanil sublingual formulation for the treatment of acute, moderate to severe postoperative pain in adult patients

, &
Pages 101-111 | Received 03 Aug 2016, Accepted 09 Nov 2016, Published online: 21 Nov 2016

References

  • Gerbershagen HJ, Aduckathil S, van Wijck AJ, et al. Pain intensity on the first day after surgery: a prospective cohort study comparing 179 surgical procedures. Anesthesiology. 2013;118:934–944.
  • Kuusniemi K, Pöyhiä R. Present-day challenges and future solutions in postoperative pain management: results from PainForum 2014. J Pain Res. 2016;9:25–36.
  • Wu CL, Raja SN. Treatment of acute postoperative pain. Lancet. 2011;377:2215–2225.
  • Piirainen A, Kokki H, Immonen S, et al. A dose-finding study of dexketoprofen in patients undergoing laparoscopic cholecystectomy: a randomized clinical trial on effects on the analgesic concentration of oxycodone. Drugs R D. 2015;15:319–328.
  • Patient-controlled analgesia. Lancet. 1980;1:289–290.
  • Viscusi ER. Patient-controlled drug delivery for acute postoperative pain management: a review of current and emerging technologies. Reg Anesth Pain Med. 2008;33:146–158.
  • Kerr D, Taylor D, Evans B. Patient-controlled intranasal fentanyl analgesia: a pilot study to assess practicality and tolerability during childbirth. Int J Obstet Anesth. 2015;24:117–123.
  • Oliashirazi A, Wilson-Byrne T, Shuler FD, et al. Patient-controlled fentanyl iontophoretic transdermal system improved postoperative mobility compared to intravenous patient-controlled analgesia morphine: a pooled analysis of randomized, controlled trials. Pain Pract. 2016 [cited 2016 May 21]. DOI:10.1111/papr.12432
  • Kokki M, Heikkinen AT, Raatikainen K, et al. Pharmacokinetics of intranasal fentanyl in parturient. Br J Anaesth. 2015;115:635–636.
  • Marwah R, Hassan S, Carvalho JC, et al. Remifentanil versus fentanyl for intravenous patient-controlled labour analgesia: an observational study. Can J Anaesth. 2012;59:246–254.
  • Mather LE. Opioids: a pharmacologist’s delight! Clin Exp Pharmacol Physiol. 1995;22:833–836.
  • Egan TD. Remifentanil pharmacokinetics and pharmacodynamics. A preliminary appraisal. Clin Pharmacokinet. 1995;29:80–94.
  • Kokki H, Kokki M. Central nervous system penetration of the opioid oxycodone. Neuropathology of drug addictions and substance misuse. Volume 3: general processes and mechanisms, prescription medications, caffeine and areca, polydrug misuse, emerging addictions and non-drug addictions. Preedy VR, editor. London: Academic Press; 2016.
  • Smith H. The metabolism of opioid agents and the clinical impact of their active metabolites. Clin J Pain. 2011;27:824–838.
  • Scott JC, Cooke JE, Stanski DR. Electroencephalographic quantitation of opioid effect: comparative pharmacodynamics of fentanyl and sufentanil. Anesthesiology. 1991;74:34–42.
  • Lorenzini K, Daali Y, Dayer P, et al. Pharmacokinetic-pharmacodynamic modelling of opioids in healthy human volunteers. A minireview. Basic Clin Pharmacol Toxicol. 2012;110:219–226.
  • Moss J. Reducing errors during patient-controlled analgesia therapy through failure mode and effects analysis. Jt Comm J Qual Patient Saf. 2010;36:359–364.
  • Rosero EB, Joshi GP. Nationwide incidence of serious complications of epidural analgesia in the United States. Acta Anaesthesiol Scand. 2016;60:810–820.
  • Skledar SJ, Lachell CM, Chelly JE. Pharmacodynamics and clinical efficacy of fentanyl iontophoretic transdermal system for post-operative pain in hospitalized patients. Expert Opin Drug Metab Toxicol. 2015;11:1925–1935.
  • Assessment report: Zalviso. EMA/612007/2015. Committee for medicinal products for human use (CHMP); 2015 [cited 2016 Sep 21]. Available from http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002784/WC500194970.pdf
  • Niemegeers CJ, Schellekens KH, Van Bever WF, et al. Sufentanil, a very potent and extremely safe intravenous morphine-like compound in mice, rats and dogs. Arzneimittelforschung. 1976;26:1551–1556.
  • Summary of product characteristics Zalviso 15 micrograms sublingual tablets. European Medicines Agency 2016; 2016 [cited 2016 Jun 6]. Available from http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002784/WC500194968.pdf
  • Volpe DA, McMahon Tobin GA, Mellon RD, et al. Uniform assessment and ranking of opioid μ receptor binding constants for selected opioid drugs. Regul Toxicol Pharmacol. 2011;59:385–390.
  • Zhu J, Xue JC, Law PY, et al. The region in the mu opioid receptor conferring selectivity for sufentanil over the delta receptor is different from that over the kappa receptor. FEBS Lett. 1996;384:198–202.
  • Wandel C, Kim R, Wood M, et al. Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein. Anesthesiology. 2002;96:913–920.
  • Kalvass JC, Olson ER, Cassidy MP, et al. Pharmacokinetics and pharmacodynamics of seven opioids in P-gp-competent mice: assessment of unbound brain EC50 and correlation of in vitro, preclinical, and clinical data. J Pharmacol Exp Ther. 2007;323:346–355.
  • Leysen JE, Gommeren W, Niemegeers CJ. [3H]Sufentanil, a superior ligand for mu-opiate receptors: binding properties and regional distribution in rat brain and spinal cord. Eur J Pharmacol. 1983;87:209–225.
  • Lahtinen P, Kokki H, Hynynen M. Remifentanil infusion does not induce opioid tolerance after cardiac surgery. J Cardiothorac Vasc Anesth. 2008;22:225–229.
  • Ummenhofer WC, Arends RH, Shen DD, et al. Comparative spinal distribution and clearance kinetics of intrathecally administered morphine, fentanyl, alfentanil, and sufentanil. Anesthesiology. 2000;92:739–753.
  • Hansdottir V, Hedner T, Woestenborghs R, et al. The CSF and plasma pharmacokinetics of sufentanil after intrathecal administration. Anesthesiology. 1991;74:264–269.
  • Kokki H, Tuovinen K, Hendolin H. The effect of intravenous ketoprofen on postoperative epidural sufentanil analgesia in children. Anesth Analg. 1999;88:1036–1041.
  • Kokki H, Tuovinen K, Hendolin H. Intravenous ketoprofen and epidural sufentanil analgesia in children after combined spinal-epidural anaesthesia. Acta Anaesthesiol Scand. 1999;43:775–779.
  • Kokki H, Ruuskanen A, Karvinen M. Comparison of epidural pain treatment with sufentanil-ropivacaine infusion with and without epinephrine in children. Acta Anaesthesiol Scand. 2002;46:647–653.
  • Jäppinen AL, Kokki H, Rasi AS, et al. Stability of sufentanil in a syringe pump under simulated epidural infusion. Int J Pharm Compd. 1998;2:466–468.
  • Jäppinen A, Turpeinen M, Kokki H, et al. Stability of sufentanil and levobupivacaine solutions and a mixture in a 0.9% sodium chloride infusion stored in polypropylene syringes. Eur J Pharm Sci. 2003;19:31–36.
  • Geller E, Chrubasik J, Graf R, et al. A randomized double-blind comparison of epidural sufentanil versus intravenous sufentanil or epidural fentanyl analgesia after major abdominal surgery. Anesth Analg. 1993;76:1243–1250.
  • Lehmann KA, Gerhard A, Horrichs-Haermeyer G, et al. Postoperative patient-controlled analgesia with sufentanil: analgesic efficacy and minimum effective concentrations. Acta Anaesthesiol Scand. 1991;35:221–226.
  • Melson TI, Boyer DL, Minkowitz HS, et al. Sufentanil sublingual tablet system vs. intravenous patient-controlled analgesia with morphine for postoperative pain control: a randomized, active-comparator trial. Pain Pract. 2014;14:679–688.
  • Vercauteren M, Boeckx E, Hanegreefs G, et al. Intranasal sufentanil for pre-operative sedation. Anaesthesia. 1988;43:270–273.
  • Minkowitz HS, Singla NK, Evashenk MA, et al. Pharmacokinetics of sublingual sufentanil tablets and efficacy and safety in the management of postoperative pain. Reg Anesth Pain Med. 2013;38:131–139.
  • Helmers JH, Noorduin H, Van Peer A, et al. Comparison of intravenous and intranasal sufentanil absorption and sedation. Can J Anaesth. 1989;36:494–497.
  • Willsie SK, Evashenk MA, Hamel LG, et al. Pharmacokinetic properties of single- and repeated-dose sufentanil sublingual tablets in healthy volunteers. Clin Ther. 2015;37:145–155.
  • Ringold FG, Minkowitz HS, Gan TJ, et al. Sufentanil sublingual tablet system for the management of postoperative pain following open abdominal surgery: a randomized, placebo-controlled study. Reg Anesth Pain Med. 2015;40:22–30.
  • Jove M, Griffin DW, Minkowitz HS, et al. Sufentanil sublingual tablet system for the management of postoperative pain after knee or hip arthroplasty: a randomized, placebo-controlled study. Anesthesiology. 2015;123:434–443.
  • Keidan I, Gravenstein D, Berkenstadt H, et al. Supplemental oxygen compromises the use of pulse oximetry for detection of apnea and hypoventilation during sedation in simulated pediatric patients. Pediatrics. 2008;122:293–298.
  • Arakawa H, Kaise M, Sumiyama K, et al. Does pulse oximetry accurately monitor a patient’s ventilation during sedated endoscopy under oxygen supplementation? Singapore Med J. 2013;54:212–215.
  • News Release. AcelRx publishes a review of hospital-based opioid patient-controlled analgesia, risks and pharmacoeconomics; 2016 Mar 25 [cited 2016 Sep 21]. http://ir.acelrx.com/phoenix.zhtml?c=241441&p=irol-newsArticle&ID=2150958
  • Lahtinen P, Kokki H, Hynynen M. Pain after cardiac surgery: a prospective cohort study of 1-year incidence and intensity. Anesthesiology. 2006;105:794–800.
  • Gomez-Brouchet A, Blaes N, Mouledous L, et al. Beneficial effects of levobupivacaine regional anaesthesia on postoperative opioid induced hyperalgesia in diabetic mice. J Transl Med. 2015;13. DOI:10.1186/s12967-015-0575-0
  • Ohnesorge H, Alpes A, Baron R, et al. Influence of intraoperative remifentanil and sufentanil on sensory perception. A randomized trial. Curr Med Res Opin. 2016;8:1–33.
  • Kennedy JM, van Rij AM. Drug absorption from the small intestine in immediate postoperative patients. Br J Anaesth. 2006;97:171–180.
  • Kokki H, Rasanen I, Lasalmi M, et al. Comparison of oxycodone pharmacokinetics after buccal and sublingual administration in children. Clin Pharmacokinet. 2006;45:745–754.
  • Kokki H, Rasanen I, Reinikainen M, et al. Pharmacokinetics of oxycodone after intravenous, buccal, intramuscular and gastric administration in children. Clin Pharmacokinet. 2004;43:613–622.
  • Kokki M, Sjövall S, Kokki H. Laparoscopic surgery: a narrative review of pharmacotherapy in pain management. Drugs. 2015;75:1867–1889.
  • Lindell-Osuagwu L, Hakkarainen M, Sepponen K, et al. Prescribing for off-label use and unauthorised medicines in three paediatric wards in Finland, the status before and after the EU paediatric regulation. J Clin Pharm Ther. 2014;39:144–153.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.